Modular nanorobot from University of Basel cut cancer cell viability to 16% by synthesizing drugs directly on cell surfaces ...

A team at the University of Basel, Switzerland, has developed a versatile nanorobot with propulsion and payload modules. The ...

Endometrial cancer remains a major gynecological malignancy with a rising incidence and limited treatment options for advanced cases. Our previous study demonstrated that the Q7 anticancer peptide ...

Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Circulating tumor DNA ...

MSCs possess tumor-homing abilities and exhibit low immunogenicity. MSCs can be engineered to deliver therapeutic agents, such as proteins, microRNAs, and drugs, directly to the tumor microenvironment ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...

Scientists at McGill University have found a way to supercharge the immune system’s natural killer (NK) cells, helping them break through the defenses tumors use to stay alive. By temporarily blocking ...

LAS VEGAS, April 10, 2026 /PRNewswire/ -- For most of modern biology, aging has been treated as a backdrop — the inevitable canvas on which individual diseases are painted. That is beginning to change ...

A therapy that has revolutionised how we treat blood and skin cancers could become even more effective. Making cancer cells stiffer bolstered the effects of immunotherapy, when the immune system is ...